For instance, metformin, a widely used treatment for diabetic patients, has been shown to inhibit the HIF-1α/PFKFB3/PFK1 pathway in HCC cells, thereby suppressing glycolysis and exerting anti-tumor effects (164). This evidence concerns the gene PFKFB3 and hepatocellular carcinoma.